<?xml version="1.0" encoding="UTF-8"?>
<p id="p0135">Furthermore, new priorities emerging from the pandemic, such as ensuring supply-chain integrity and managing increasing fake medicines,
 <xref rid="bib49" ref-type="bibr">
  <sup>49</sup>
 </xref>
 <sup>,</sup>
 <xref rid="bib50" ref-type="bibr">
  <sup>50</sup>
 </xref> may require health authorities to seek additional tools and resources. In addition, the pandemic has affected the implementation of some new provisions, such as the EU Medical Device Regulation
 <xref rid="bib51" ref-type="bibr">
  <sup>51</sup>
 </xref> or Australia's adoption of TGO 91 labels,
 <xref rid="bib52" ref-type="bibr">
  <sup>52</sup>
 </xref> to which resources have already been initially allocated.
</p>
